BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 37108564)

  • 1. Proteolytic Activity of the Paracaspase MALT1 Is Involved in Epithelial Restitution and Mucosal Healing.
    Wittner L; Wagener L; Wiese JJ; Stolzer I; Krug SM; Naschberger E; Jackstadt R; Beyaert R; Atreya R; Kühl AA; Sturm G; Gonzalez-Acera M; Patankar JV; Becker C; Siegmund B; Trajanoski Z; Winner B; Neurath MF; Schumann M; Günther C
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autocleavage of the paracaspase MALT1 at Arg-781 attenuates NF-κB signaling and regulates the growth of activated B-cell like diffuse large B-cell lymphoma cells.
    Wu CH; Yang YH; Chen MR; Tsai CH; Cheng AL; Doong SL
    PLoS One; 2018; 13(6):e0199779. PubMed ID: 29953499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.
    Bardet M; Unterreiner A; Malinverni C; Lafossas F; Vedrine C; Boesch D; Kolb Y; Kaiser D; Glück A; Schneider MA; Katopodis A; Renatus M; Simic O; Schlapbach A; Quancard J; Régnier CH; Bold G; Pissot-Soldermann C; Carballido JM; Kovarik J; Calzascia T; Bornancin F
    Immunol Cell Biol; 2018 Jan; 96(1):81-99. PubMed ID: 29359407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ancient Origin of the CARD-Coiled Coil/Bcl10/MALT1-Like Paracaspase Signaling Complex Indicates Unknown Critical Functions.
    Staal J; Driege Y; Haegman M; Borghi A; Hulpiau P; Lievens L; Gul IS; Sundararaman S; Gonçalves A; Dhondt I; Pinzón JH; Braeckman BP; Technau U; Saeys Y; van Roy F; Beyaert R
    Front Immunol; 2018; 9():1136. PubMed ID: 29881386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MALT1 Proteolytic Activity Suppresses Autoimmunity in a T Cell Intrinsic Manner.
    Demeyer A; Skordos I; Driege Y; Kreike M; Hochepied T; Baens M; Staal J; Beyaert R
    Front Immunol; 2019; 10():1898. PubMed ID: 31474984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALT1 inhibitors prevent the development of DSS-induced experimental colitis in mice via inhibiting NF-κB and NLRP3 inflammasome activation.
    Liu W; Guo W; Hang N; Yang Y; Wu X; Shen Y; Cao J; Sun Y; Xu Q
    Oncotarget; 2016 May; 7(21):30536-49. PubMed ID: 27105502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of MALT1 protease activity is selectively toxic for activated B cell-like diffuse large B cell lymphoma cells.
    Ferch U; Kloo B; Gewies A; Pfänder V; Düwel M; Peschel C; Krappmann D; Ruland J
    J Exp Med; 2009 Oct; 206(11):2313-20. PubMed ID: 19841089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function and targeting of MALT1 paracaspase in cancer.
    O'Neill TJ; Tofaute MJ; Krappmann D
    Cancer Treat Rev; 2023 Jun; 117():102568. PubMed ID: 37126937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological inhibition of MALT1 protease activity suppresses endothelial activation via enhancing MCPIP1 expression.
    Li Y; Huang S; Huang X; Li X; Falcon A; Soutar A; Bornancin F; Jiang Z; Xin HB; Fu M
    Cell Signal; 2018 Oct; 50():1-8. PubMed ID: 29913212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALT1-dependent cleavage of CYLD promotes NF-κB signaling and growth of aggressive B-cell receptor-dependent lymphomas.
    Minderman M; Lantermans HC; Grüneberg LJ; Cillessen SAGM; Bende RJ; van Noesel CJM; Kersten MJ; Pals ST; Spaargaren M
    Blood Cancer J; 2023 Mar; 13(1):37. PubMed ID: 36922488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
    Afonina IS; Van Nuffel E; Baudelet G; Driege Y; Kreike M; Staal J; Beyaert R
    EMBO Rep; 2016 Jun; 17(6):914-27. PubMed ID: 27113748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probes to monitor activity of the paracaspase MALT1.
    Hachmann J; Edgington-Mitchell LE; Poreba M; Sanman LE; Drag M; Bogyo M; Salvesen GS
    Chem Biol; 2015 Jan; 22(1):139-47. PubMed ID: 25556944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
    Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
    Front Immunol; 2020; 11():576651. PubMed ID: 33042160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MALT1 auto-proteolysis is essential for NF-κB-dependent gene transcription in activated lymphocytes.
    Baens M; Bonsignore L; Somers R; Vanderheydt C; Weeks SD; Gunnarsson J; Nilsson E; Roth RG; Thome M; Marynen P
    PLoS One; 2014; 9(8):e103774. PubMed ID: 25105596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MALT1-Dependent Cleavage of HOIL1 Modulates Canonical NF-κB Signaling and Inflammatory Responsiveness.
    Fung SY; Lu HY; Sharma M; Sharma AA; Saferali A; Jia A; Abraham L; Klein T; Gold MR; Noterangelo LD; Overall CM; Turvey SE
    Front Immunol; 2021; 12():749794. PubMed ID: 34721419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allosteric MALT1 inhibitor is a molecular corrector rescuing function in an immunodeficient patient.
    Quancard J; Klein T; Fung SY; Renatus M; Hughes N; Israël L; Priatel JJ; Kang S; Blank MA; Viner RI; Blank J; Schlapbach A; Erbel P; Kizhakkedathu J; Villard F; Hersperger R; Turvey SE; Eder J; Bornancin F; Overall CM
    Nat Chem Biol; 2019 Mar; 15(3):304-313. PubMed ID: 30692685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malt1 self-cleavage is critical for regulatory T cell homeostasis and anti-tumor immunity in mice.
    Baens M; Stirparo R; Lampi Y; Verbeke D; Vandepoel R; Cools J; Marynen P; de Bock CE; Bornschein S
    Eur J Immunol; 2018 Oct; 48(10):1728-1738. PubMed ID: 30025160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MALT1 is a potential therapeutic target in glioblastoma and plays a crucial role in EGFR-induced NF-κB activation.
    Liu X; Yue C; Shi L; Liu G; Cao Q; Shan Q; Wang Y; Chen X; Li H; Wang J; Gao S; Niu M; Yu R
    J Cell Mol Med; 2020 Jul; 24(13):7550-7562. PubMed ID: 32452133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal lymphocyte homeostasis and function in MALT1 protease-resistant HOIL-1 knock-in mice.
    Skordos I; Driege Y; Haegman M; Kreike M; Staal J; Demeyer A; Beyaert R
    FEBS J; 2023 Apr; 290(8):2032-2048. PubMed ID: 36479846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.